Elizabeth L. Barry

5.1k total citations
79 papers, 2.2k citations indexed

About

Elizabeth L. Barry is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elizabeth L. Barry has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Elizabeth L. Barry's work include Colorectal Cancer Screening and Detection (21 papers), Vitamin D Research Studies (17 papers) and Cancer, Lipids, and Metabolism (13 papers). Elizabeth L. Barry is often cited by papers focused on Colorectal Cancer Screening and Detection (21 papers), Vitamin D Research Studies (17 papers) and Cancer, Lipids, and Metabolism (13 papers). Elizabeth L. Barry collaborates with scholars based in United States, Canada and United Kingdom. Elizabeth L. Barry's co-authors include John A. Baron, Robert S. Bresalier, Robert S. Sandler, Deane F. Mosher, Dennis J. Ahnen, Maria V. Grau, Leila A. Mott, Judy R. Rees, Roberd M. Bostick and D F Mosher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Elizabeth L. Barry

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth L. Barry United States 28 617 564 487 418 391 79 2.2k
Christoph Otto Germany 28 477 0.8× 382 0.7× 869 1.8× 250 0.6× 502 1.3× 133 2.8k
Beom Jin Lim South Korea 29 434 0.7× 249 0.4× 582 1.2× 547 1.3× 465 1.2× 163 2.8k
Sung-Kil Lim South Korea 33 680 1.1× 622 1.1× 994 2.0× 137 0.3× 558 1.4× 107 3.3k
Babu J. Padanilam United States 32 437 0.7× 288 0.5× 1.4k 2.8× 205 0.5× 306 0.8× 68 2.8k
Jacob van den Born Netherlands 36 346 0.6× 260 0.5× 888 1.8× 277 0.7× 553 1.4× 119 3.3k
Richard D. Patten United States 30 340 0.6× 411 0.7× 1.2k 2.5× 341 0.8× 517 1.3× 53 3.8k
Shih‐Ping Cheng Taiwan 29 411 0.7× 571 1.0× 647 1.3× 298 0.7× 688 1.8× 149 2.6k
Satoru Yamamoto Japan 26 481 0.8× 497 0.9× 572 1.2× 872 2.1× 304 0.8× 108 2.6k
Toshiaki Nakano Japan 25 175 0.3× 373 0.7× 613 1.3× 328 0.8× 482 1.2× 203 2.5k

Countries citing papers authored by Elizabeth L. Barry

Since Specialization
Citations

This map shows the geographic impact of Elizabeth L. Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth L. Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth L. Barry more than expected).

Fields of papers citing papers by Elizabeth L. Barry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth L. Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth L. Barry. The network helps show where Elizabeth L. Barry may publish in the future.

Co-authorship network of co-authors of Elizabeth L. Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth L. Barry. A scholar is included among the top collaborators of Elizabeth L. Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth L. Barry. Elizabeth L. Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Passarelli, Michael N., Jeffrey G. McDonald, Bonne M. Thompson, et al.. (2024). Plasma Concentrations of Multiple Oxysterols and Risk of Colorectal Adenomas. Cancer Prevention Research. 17(11). 517–524. 1 indexed citations
2.
Barry, Elizabeth L., Veronika Fedirko, Ken Liu, et al.. (2022). Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas. Cancer Prevention Research. 15(8). 521–531. 5 indexed citations
3.
Crockett, Seth D., Elizabeth L. Barry, Leila A. Mott, et al.. (2022). Predictors of Incident Serrated Polyps: Results from a Large Multicenter Clinical Trial. Cancer Epidemiology Biomarkers & Prevention. 31(5). 1058–1067. 4 indexed citations
4.
Passarelli, Michael N., Jeffrey G. McDonald, Bonne M. Thompson, et al.. (2022). Association of demographic and health characteristics with circulating oxysterol concentrations. Journal of clinical lipidology. 16(3). 345–355. 6 indexed citations
5.
Passarelli, Michael N., Bonne M. Thompson, Jeffrey G. McDonald, et al.. (2021). Circulating 27-hydroxycholesterol and Risk of Colorectal Adenomas and Serrated Polyps. Cancer Prevention Research. 14(4). 479–488. 9 indexed citations
6.
Passarelli, Michael N., Margaret R. Karagas, Leila A. Mott, et al.. (2020). Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial. American Journal of Clinical Nutrition. 112(6). 1532–1539. 15 indexed citations
7.
Barry, Elizabeth L., Veronika Fedirko, Karan Uppal, et al.. (2020). Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Cancer Prevention Research. 13(10). 863–876. 5 indexed citations
8.
Calderwood, Audrey H., John A. Baron, Leila A. Mott, et al.. (2019). No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial. Cancer Prevention Research. 12(5). 295–304. 25 indexed citations
9.
Hodge, Rebecca D., Hannah Mandle, Stephen Ray, et al.. (2018). Effects of Supplemental Calcium and Vitamin D on Expression of Toll-Like Receptors and Phospho-IKKα/β in the Normal Rectal Mucosa of Colorectal Adenoma Patients. Cancer Prevention Research. 11(11). 707–716. 1 indexed citations
10.
Rees, Judy R., Carolyn Morris, Janet L. Peacock, et al.. (2017). Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk. Cancer Prevention Research. 10(8). 451–458. 13 indexed citations
11.
Rees, Judy R., Leila A. Mott, Elizabeth L. Barry, et al.. (2016). Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults. Journal of Nutrition. 146(11). 2312–2324. 20 indexed citations
12.
Liu, Siyu, Elizabeth L. Barry, John A. Baron, et al.. (2016). Effects of supplemental calcium and vitamin D on the APC/β‐catenin pathway in the normal colorectal mucosa of colorectal adenoma patients. Molecular Carcinogenesis. 56(2). 412–424. 20 indexed citations
13.
Fedirko, Veronika, Patrick T. Bradshaw, Jane C. Figueiredo, et al.. (2015). Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prevention Research. 8(11). 1061–1068. 105 indexed citations
14.
Crockett, Seth D., Leila A. Mott, Elizabeth L. Barry, et al.. (2014). C-reactive Protein and Risk of Colorectal Adenomas or Serrated Polyps: A Prospective Study. Cancer Prevention Research. 7(11). 1122–1127. 10 indexed citations
15.
Wallace, Kristin, Carol A. Burke, Dennis J. Ahnen, et al.. (2014). The Association of Age and Race and the Risk of Large Bowel Polyps. Cancer Epidemiology Biomarkers & Prevention. 24(2). 448–453. 7 indexed citations
16.
Barry, Elizabeth L., Elizabeth M. Poole, John A. Baron, et al.. (2012). CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes & Control. 24(1). 47–54. 11 indexed citations
17.
Wallace, Kristin, Maria V. Grau, A. Joan Levine, et al.. (2010). Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa. Cancer Prevention Research. 3(12). 1552–1564. 88 indexed citations
18.
Barry, Elizabeth L., John A. Baron, Maria V. Grau, et al.. (2006). Ornithine Decarboxylase Polymorphism Modification of Response to Aspirin Treatment for Colorectal Adenoma Prevention. JNCI Journal of the National Cancer Institute. 98(20). 1494–1500. 31 indexed citations
19.
Sneddon, W. Bruce, Elizabeth L. Barry, Bonita Coutermarsh, et al.. (1998). Regulation of Renal Parathyroid Hormone Receptor Expression by 1,25-Dihydroxyvitamin D<sub>3</sub> and Retinoic Acid. Cellular Physiology and Biochemistry. 8(5). 261–277. 16 indexed citations
20.
Barry, Elizabeth L. & Deane F. Mosher. (1990). Binding and degradation of blood coagulation factor XIII by cultured fibroblasts.. Journal of Biological Chemistry. 265(16). 9302–9307. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026